# ğŸš€ Personalized Insulin Dosage Prediction Using Hybrid LSTMâ€“GRU  

## ğŸ“Œ Project Overview  
This project introduces a **Hybrid Deep Learning Framework** for predicting personalized insulin dosages in diabetic patients.  
By combining **LSTM** and **GRU** layers with residual learning, the model captures both short-term glucose fluctuations and long-term physiological patterns.  

The model processes the **AIM94 dataset**, applying advanced preprocessing and temporal feature engineering to transform irregular event logs into structured time-series suitable for deep learning.  

---

## ğŸ”‘ Key Highlights  
- ğŸŒ¿ **Residual Hybrid Architecture** â†’ LSTM + GRU with skip connections for stable and efficient learning.  
- ğŸ›  **Advanced Preprocessing** â†’ Converts raw event-based records into structured multivariate time series.  
- â³ **Sliding Window Modeling** â†’ Generates sequences to forecast insulin dosage.  
- ğŸ“Š **Superior Performance** â†’ Achieved **RÂ² = 0.805**, **MAE = 1.29**, and **MSE = 3.27**, improving accuracy significantly compared to baselines.  

---

## ğŸ¯ Objectives  
- Develop a robust hybrid deep learning model for insulin prediction.  
- Improve accuracy and stability over traditional models.  
- Provide a foundation for **personalized diabetes management systems**.  

---

## ğŸ“‚ Dataset  
- Source: **AIM94 Dataset**  
- Type: Multivariate time-series (event-based logs).  
- Preprocessing: Missing value handling, normalization, and feature engineering.  

---

## âš™ï¸ Methodology  
1. **Data Preprocessing** â€“ cleaning, normalization, and structuring.  
2. **Sliding Window Generation** â€“ creating input sequences.  
3. **Model Design** â€“ Hybrid LSTM + GRU with residual connections.  
4. **Training & Validation** â€“ optimizing loss and tuning hyperparameters.  
5. **Evaluation** â€“ measuring RÂ², MAE, and MSE metrics.  

---

## ğŸ“ˆ Results  
- RÂ² = **0.805**  
- MAE = **1.29**  
- MSE = **3.27**  
- Outperformed baseline models significantly.  

---

## ğŸ— Future Scope  
- Integrating Reinforcement Learning for real-time dosage optimization.  
- Extending to continuous glucose monitoring (CGM) devices.  
- Deploying as a **mobile application** for personalized healthcare.  
